SCHEMBL20153716

SCHEMBL20153716

COc1ccc(C(CC(=O)OC(C)(C)C)n2ncc3c(Br)cccc32)cn1

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 1/20 0.33
SCN9A Q15858 3/20 0.33
OXTR P30559 1/20 0.32
MTNR1A P48039 1/20 0.32
MTNR1B P49286 1/20 0.32
SCN10A Q9Y5Y9 2/20 0.31
HPGD P15428 1/20 0.31
ITGB3 P05106 1/20 0.31
ITGAV P06756 1/20 0.31
DGAT1 O75907 1/20 0.31
P2RX7 Q99572 1/20 0.31
NR3C1 P04150 1/20 0.30
POLB P06746 1/20 0.30
KMT2A Q03164 1/20 0.30
CTSA P10619 1/20 0.30
CHRNA7 P36544 1/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20153360 0.75 OXTR (0.34) ALDH1A1KDM4EOXTRMTNR1AMTNR1B
SCHEMBL20153715 0.74 ITGAV (0.39) ITGB3ITGAV
SCHEMBL20153717 0.74 FGFR4 (0.36) ITGB3ITGAV
SCHEMBL7018373 0.71 NNMT (0.42) ALDH1A1KDM4EOXTRMTNR1AMTNR1B
SCHEMBL13829314 0.71 NNMT (0.42) ALDH1A1KDM4EOXTRMTNR1AMTNR1B
SCHEMBL23348634 0.70 KDM4E (0.45) ALDH1A1KDM4ESCN9ASCN10AHPGD
SCHEMBL30188562 0.70 KDM4E (0.45) ALDH1A1KDM4ESCN9ASCN10AHPGD
SCHEMBL21282967 0.67 ITGB3 (0.35) ITGB3ITGAV
SCHEMBL21311735 0.67 ITGB3 (0.38) ITGB3ITGAV
SCHEMBL13829144 0.66 KMT2A (0.41) ALDH1A1ITGB3ITGAVPOLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3538519-B1 INDAZOLE DERIVATIVES AS ALPHA V INTEGRIN ANTAGONISTS BRISTOL MYERS SQUIBB CO (US) 2021-07-28 EP disclosed
WO-2018089357-A1 INDAZOLE DERIVATIVES AS αV INTEGRIN ANTAGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-05-17 WO disclosed